drugset / Press release

TSND-201 (Methylone) as a Treatment for PTSD: Rapid, Robust, and Long-Lasting Activity in Phase 2

2025-05-27 · Transcend Therapeutics · original transcendtherapeutics.com ↗

Summary of Presentation: TSND-201 is a non-hallucinogenic, rapid acting neuroplastogen that increases neurite outgrowth Preclinical results demonstrate rapid, robust, and long-lasting benefit tests of PTSD, anxiety, depression View Poster

The release as fetched from its publisher. transcendtherapeutics.com ↗